Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban Pharmacokinetics in Bariatric Patients
NCT02406885Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thromboembolism (VTE), sponsored by Johns Hopkins University. Started Jul 2017; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02406885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406885.